[go: up one dir, main page]

NO20015295L - Farmasöytisk preparat i enhetsform inneholdende acetylsalicylsyre og klopidogrelhydrogensulfat - Google Patents

Farmasöytisk preparat i enhetsform inneholdende acetylsalicylsyre og klopidogrelhydrogensulfat

Info

Publication number
NO20015295L
NO20015295L NO20015295A NO20015295A NO20015295L NO 20015295 L NO20015295 L NO 20015295L NO 20015295 A NO20015295 A NO 20015295A NO 20015295 A NO20015295 A NO 20015295A NO 20015295 L NO20015295 L NO 20015295L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
unit form
hydrogen sulfate
acetylsalicylic acid
form containing
Prior art date
Application number
NO20015295A
Other languages
English (en)
Other versions
NO20015295D0 (no
Inventor
Bernard Abramovici
Jean Lheritier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20015295D0 publication Critical patent/NO20015295D0/no
Publication of NO20015295L publication Critical patent/NO20015295L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20015295A 1999-04-30 2001-10-29 Farmasöytisk preparat i enhetsform inneholdende acetylsalicylsyre og klopidogrelhydrogensulfat NO20015295L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905497A FR2792836B3 (fr) 1999-04-30 1999-04-30 Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
PCT/FR2000/001086 WO2000066130A1 (fr) 1999-04-30 2000-04-25 Composition pharmaceutique sous forme unitaire contenant de l'acide acetylsalicylique et de l'hydrogenosulfate de clopidogrel

Publications (2)

Publication Number Publication Date
NO20015295D0 NO20015295D0 (no) 2001-10-29
NO20015295L true NO20015295L (no) 2001-12-21

Family

ID=9545071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015295A NO20015295L (no) 1999-04-30 2001-10-29 Farmasöytisk preparat i enhetsform inneholdende acetylsalicylsyre og klopidogrelhydrogensulfat

Country Status (24)

Country Link
EP (1) EP1178809A1 (no)
JP (1) JP2002543137A (no)
KR (1) KR20020005735A (no)
CN (1) CN1359294A (no)
AR (1) AR023789A1 (no)
AU (1) AU4303600A (no)
BR (1) BR0010194A (no)
CA (1) CA2371231A1 (no)
CZ (1) CZ20013887A3 (no)
EA (1) EA200100959A1 (no)
EE (1) EE200100559A (no)
FR (1) FR2792836B3 (no)
HK (1) HK1041823A1 (no)
HU (1) HUP0202329A2 (no)
IL (1) IL145648A0 (no)
IS (1) IS6084A (no)
MX (1) MXPA01011071A (no)
NO (1) NO20015295L (no)
NZ (1) NZ514248A (no)
PL (1) PL351923A1 (no)
SK (1) SK15542001A3 (no)
TR (1) TR200103039T2 (no)
UY (1) UY26131A1 (no)
WO (1) WO2000066130A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1350511B1 (en) 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
RU2180848C1 (ru) * 2001-01-30 2002-03-27 Плотников Марк Борисович Средство с антиагрегантной и гемореологической активностью
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
JP4917255B2 (ja) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 サリチル酸類含有経口組成物
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
AU2006259606A1 (en) * 2005-06-13 2006-12-28 Elan Pharma International, Limited Nanoparticulate clopidogrel and aspirin combination formulations
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
CA2618187C (en) * 2005-09-21 2011-06-21 Chong Kun Dang Pharmaceutical Corp. Novel resinate complex of s-clopidogrel and production method thereof
KR20070044323A (ko) * 2005-10-24 2007-04-27 에스케이케미칼주식회사 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제
US20100145053A1 (en) * 2006-04-05 2010-06-10 Cadila Healthcare Limited Modified release clopidogrel formulation
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
CN101951896B (zh) * 2008-02-22 2012-11-28 韩兀生物制药株式会社 复合制剂
CN101695496A (zh) * 2009-10-15 2010-04-21 苏春华 一种含有三氟柳和氯吡格雷的药物组合物
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
RU2484820C2 (ru) * 2011-02-24 2013-06-20 Общество с ограниченной ответственностью "Озон" Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
JP6004524B2 (ja) * 2012-07-11 2016-10-12 大原薬品工業株式会社 クロピドグレル硫酸塩含有錠剤の製造方法
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
CN104434932B (zh) * 2014-12-18 2017-05-24 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法
WO2017037741A1 (en) * 2015-09-02 2017-03-09 Sun Pharmaceutical Industries Ltd Compact solid dosage form of aspirin and clopidogrel
CN115737578A (zh) * 2022-11-23 2023-03-07 石家庄四药有限公司 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2744918B1 (fr) 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel

Also Published As

Publication number Publication date
PL351923A1 (en) 2003-06-30
EA200100959A1 (ru) 2002-06-27
TR200103039T2 (tr) 2002-01-21
JP2002543137A (ja) 2002-12-17
IS6084A (is) 2001-09-25
NO20015295D0 (no) 2001-10-29
HUP0202329A2 (en) 2002-10-28
IL145648A0 (en) 2002-06-30
FR2792836B3 (fr) 2001-07-27
EE200100559A (et) 2003-02-17
BR0010194A (pt) 2002-02-13
CA2371231A1 (en) 2000-11-09
UY26131A1 (es) 2000-12-29
HK1041823A1 (zh) 2002-07-26
AU4303600A (en) 2000-11-17
NZ514248A (en) 2003-06-30
KR20020005735A (ko) 2002-01-17
MXPA01011071A (es) 2002-07-22
FR2792836A1 (fr) 2000-11-03
AR023789A1 (es) 2002-09-04
EP1178809A1 (fr) 2002-02-13
WO2000066130A1 (fr) 2000-11-09
CZ20013887A3 (cs) 2002-02-13
SK15542001A3 (sk) 2002-02-05
CN1359294A (zh) 2002-07-17

Similar Documents

Publication Publication Date Title
NO20015295L (no) Farmasöytisk preparat i enhetsform inneholdende acetylsalicylsyre og klopidogrelhydrogensulfat
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
IS6205A (is) Lyfja- og næringarsamsetningar sem innihalda nauðsynlegar fitusýrur og hómósystein-lækkandi miðla
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
NO20012245L (no) Anthranilsyreamider og anvendelse derav som medikamenter
DK1150961T3 (da) Pyrazolcarboxylsyrederivater, fremstilling af disse og farmaceutiske præparater indeholdende disse
NO20013302L (no) Medisinsk preparat inneholdende et opioid og en <alfa>- agonist
NO20020374D0 (no) Karboksylsyreamider, medikamenter inneholdende disse forbindelser, deres anvendelse og fremstilling
NO20010078L (no) Fenoksyeddiksyrederivat og farmasøytisk sammensetning omfattende det samme
DK200300344U1 (da) Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
PT1268396E (pt) Eteres difenilicos utilizados em terapeutica
HUP0300709A3 (en) Pharmaceutical composition comprising pemetrexed together with monothiaglycerol l-cystein or thioglycolic acid
DK1290200T3 (da) Proteintranslokation i planteceller
NO20024994L (no) Pulver inneholdende konjugert linolsyre
PL395021A1 (pl) Środki zawierające kwas karboksylowy i ich zastosowanie w uprawie roślin
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
DE60038867D1 (de) Dreifache rückläufige Anzeige und deren Mechanismus
PL343635A1 (en) Salicylic acid pathway genes and their use for the induction of resistance in plants
NO20013117D0 (no) Kosmetisk preparat av spray-type og matriks anvendt i preparatet for dermal administrering
DE60006625D1 (de) Zusammensetzung mit kontrollierter Freigabe enthaltend 5-Isosorbidnitrat und Acetylsalicylsäure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application